Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria

被引:56
作者
Corsonello, A
Ientile, R
Buemi, M
Cucinotta, D
Mauro, VN
Macaione, S
Corica, F
机构
[1] Univ Messina, Dept Internal Med, I-98100 Messina, Italy
[2] INRCA, Div Geriatr Med, Cosenza, Italy
[3] Univ Messina, Inst Biochem Sci & Clin Biochem, I-98100 Messina, Italy
关键词
magnesium ion-selective electrodes; non-insulin-dependent diabetes mellitus; diabetic nephropathy;
D O I
10.1159/000013582
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: The association between microalbuminuria and magnesium depletion is a controversial issue, and serum ionized magnesium levels have not been previously studied in patients with different grades of diabetic nephropathy. Therefore, the aim of th is study was to evaluate circulating ionized magnesium concentrations in patients with non-insulin-dependent diabetes mellitus (NIDDM) and incipient or overt diabetic nephropathy. Methods: We measured fasting plasma glucose, creatinine, creatinine clearance estimate, total cholesterol and triglycerides, and serum ionized magnesium lion-selective electrodes, ISE) in 30 NIDDM patients with urinary albumin excretion rate (UAER) <20 mu g/min (normoalbuminuria), 30 NIDDM patients with microalbuminuria (20 < UAER < 200 mu g/min), 30 NDDM patients with clinical proteinuria (UAER >200 mu g/min), and 20 healthy subjects. Results: Serum ionized magnesium levels were significantly reduced in diabetic patients when compared to control subjects (0.39 +/- 0.06 vs. 0.58 +/- 0.05 mmol/l, p < 0.001). Moreover, diabetic patients with microalbuminuria or clinical proteinuria showed a significant decrease in serum ionized magnesium with respect to normoalbuminuria group (normoalbuminuria: 0.45 +/- 0.02 mmol/l; microalbuminuria: 0.36 +/- 0.05 mmol/l, p < 0.001; clinical proteinuria: 0.35 +/- 0.04 mmol/l, p < 0.001). Serum ionized magnesium showed a significant negative correlation with plasma HbA1c and triglycerides in both microalbuminuria and clinical proteinuria groups. Multiple linear regression analysis showed that circulating ionized magnesium levels decrease together with the increase of plasma HbA1c and triglycerides in NIDDM patients with incipient or overt nephropathy, also after adjusting for age, sex, BMI, diabetes duration, systolic and diastolic blood pressure, hypoglycemic therapy, plasma creatinine, creatinine clearance, plasma cholesterol and fasting glucose. Conclusions: Microalbuminuria and clinical proteinuria, as well as poor glycometabolic control and hypertriglyceridemia, a re associated to relevant alterations in magnesium metabolism, and the measurement of serum ionized magnesium seems to represent a useful biochemical tool for the study of magnesium disturbances in patients with different grades of diabetic nephropathy. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 30 条
[1]   Plasma, erythrocyte and platelet magnesium levels in type 1 diabetic patients with microalbuminuria and clinical proteinuria [J].
Allegra, A ;
Corsonello, A ;
Buemi, M ;
D'Angelo, R ;
Di Benedetto, A ;
Bonanzinga, S ;
Cucinotta, D ;
Ientile, R ;
Corica, F .
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 1997, 11 (03) :154-157
[2]   MAGNESIUM DIETARY-INTAKE MODULATES BLOOD LIPID-LEVELS AND ATHEROGENESIS [J].
ALTURA, BT ;
BRUST, M ;
BLOOM, S ;
BARBOUR, RL ;
STEMPAK, JG ;
ALTURA, BM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1840-1844
[3]   HYPOMAGNESEMIA IN CHILDHOOD IDDM AND RISK OF NEPHROPATHY [J].
ARSLANOGLU, I ;
GUNOZ, H .
DIABETOLOGIA, 1995, 38 (05) :629-629
[4]   Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men [J].
Ascherio, A ;
Rimm, EB ;
Hernán, MA ;
Giovannucci, EL ;
Kawachi, I ;
Stampfer, MJ ;
Willett, WC .
CIRCULATION, 1998, 98 (12) :1198-1204
[5]   Changes in plasma, erythrocyte, and platelet magnesium levels in normotensive and hypertensive obese subjects during oral glucose tolerance test [J].
Corica, F ;
Allegra, A ;
Ientile, R ;
Buemi, H ;
Corsonello, A ;
Bonanzinga, S ;
Macaione, S ;
Ceruso, D .
AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (02) :128-136
[6]   Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus [J].
Corica, F ;
Ientile, R ;
Allegra, A ;
Romano, G ;
Cangemi, F ;
DiBenedetto, A ;
Buemi, M ;
Cucinotta, D ;
Ceruso, D .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1996, 51 (01) :13-21
[7]  
Corica Francesco, 1994, Magnesium Research, V7, P43
[8]   Effect of moderate improvement in metabolic control on magnesium and lipid concentrations in patients with type 1 diabetes [J].
Djurhuus, MS ;
Henriksen, JE ;
Klitgaard, NAH ;
Blaabjerg, O ;
Thye-Ronn, P ;
Altura, BM ;
Altura, BT ;
Beck-Nielsen, H .
DIABETES CARE, 1999, 22 (04) :546-554
[9]  
DURLACH J, 1985, MAGNESIUM PARATIQUE, P177
[10]   MAGNESIUM LEVELS IN PLASMA, ERYTHROCYTE AND URINE IN PATIENTS WITH DIABETES-MELLITUS [J].
FUJII, S ;
TAKEMURA, T ;
WADA, M ;
AKAI, T ;
OKUDA, K .
HORMONE AND METABOLIC RESEARCH, 1982, 14 (03) :161-162